Mace Rothenberg's most recent trade in Tango Therapeutics Inc was a trade of 37,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tango Therapeutics Inc | Mace Rothenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Mace Rothenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 6,250 | 37,500 | - | 0 | Common Stock | |
| Surrozen Inc | Mace Rothenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 1,333 | 1,333 | - | - | Option (right to buy) | |
| Tango Therapeutics Inc | Mace Rothenberg | Director | Purchase of securities on an exchange or from another person at price $ 3.78 per share. | 14 Nov 2024 | 10,000 | 31,250 | - | 3.8 | 37,800 | Common Stock |
| Tango Therapeutics Inc | Mace Rothenberg | Director | Purchase of securities on an exchange or from another person at price $ 3.62 per share. | 14 Nov 2024 | 10,000 | 21,250 | - | 3.6 | 36,200 | Common Stock |
| Tango Therapeutics Inc | Mace Rothenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Mace Rothenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 6,250 | 11,250 | - | 0 | Common Stock | |
| Surrozen Inc | Mace Rothenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 1,333 | 1,333 | - | - | Option (right to buy) | |
| Tango Therapeutics Inc | Mace Rothenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Mace Rothenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 5,000 | 5,000 | - | 0 | Common Stock | |
| Surrozen Inc | Mace Rothenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 20,000 | 20,000 | - | - | Option (right to buy) | |
| Tango Therapeutics Inc | Mace Rothenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Surrozen Inc | Mace Rothenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 20,000 | 20,000 | - | - | Option (right to buy) |